Panacea Biotec, one of India’s leading biotechnology companies, is proud to announce two major developments: the launch of the world’s first fully-liquid wP-IPV based Pentavalent vaccine, EasyFourPol, in India and the registration of Valganciclovir 50 mg/ml Powder for Oral Solution in Germany by its subsidiary, Panacea Biotec Germany GmbH. EasyFourPol is a milestone in paediatric […]
Panacea Biotec, an Indian biotechnology company, has been awarded supply orders worth $127.3 million from United Nations Children’s Fund (UNICEF) and Pan American Health Organization (PAHO) for the supply of Easyfive-TT (DTwP-HepB-Hib), pentavalent vaccine. The award from UNICEF is for supplying nearly 99.7 million doses of Easyfive-TT vaccine during calendar years 2023-2027 and is worth […]
Panacea Biotec said that its fully-owned subsidiary Biotec Pharma Ltd. (PBPL) has agreed to sell its domestic formulations brands for India and Nepal to Mankind Pharma for INR 1,872 crores. According to Panacea Biotec, its consolidated revenue is INR 634.78 crores and the domestic formulations brands that are part of the deal had revenue from […]
Panacea Biotec and the Russian Direct Investment Fund (RDIF) said that the former has supplied the first shipment of the second component of the Russian Sputnik V Covid vaccine manufactured by it for sale in India. According to the Indian vaccine and pharma manufacturer, the first shipment which was made comprised a million doses of […]
Panacea Biotec has secured a manufacturing license from the Drugs Controller General of India (DCGI) for Sputnik V vaccine against Covid-19 following its collaboration with the Russian Direct Investment Fund (RDIF). According to the vaccine producer, the license is an essential condition for using Sputnik V vaccine produced by it in India. Earlier, batches produced […]
Russia’s sovereign wealth fund – Russian Direct Investment Fund (RDIF) and Indian vaccine and pharma manufacturer Panacea Biotec have launched production of the Sputnik V Covid vaccine in India. According to RDIF, the first batch of the Sputnik V vaccine produced at Panacea Biotec’s facilities at Baddi in Himachal Pradesh will be shipped to the […]